This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

Equate-Muscle & Back Pain Relief -8 (2016-01-22)

Starting date:
January 22, 2016
Posting date:
February 2, 2016
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-56956

Affected Products

Equate-Muscle & Back Pain Relief -8

Reason

Product did not meet stability specification for Codeine Phosphate assay.

Depth of distribution

Distributed down to retailers in Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland, Nova Scotia, Ontario, Quebec and Saskatchewan.

Affected products

Equate-Muscle & Back Pain Relief -8

DIN, NPN, DIN-HIM
DIN 02248977
Dosage form

Caplets

Strength
  • Methocarbamol 400 mg
  • Acetaminophen 325 mg
  • Codeine phosphate 8 mg
Lot or serial number
  • Lot 656306
  • Lot 656307
Companies
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA